NASA in nasal spray deal to combat motion sickness

CAPE CANAVERAL, Florida (Reuters) – NASA has signed an agreement with a California-based startup to develop and market a nasal spray for motion sickness, the U.S. space agency said on Friday. NASA will work with privately owned Epiomed Therapeutics of Irvine, California, on the nasal spray, which has been shown to be a fast-acting treatment for motion sickness. About half the astronauts who fly in space develop space motion sickness, with symptoms that anyone nauseated or light-headed from more terrestrial forms of travel will recognize. …

NASA’s massive renovation

The best time to do a little renovating is when everyone is out of the house — something homeowners know and something NASA appears to appreciate too. The space agency is experiencing empty-nest syndrome in a big way, with the shuttles heading for museum retirement and the next manned American space vehicle not scheduled to fly until 2016 — unless it’s 2018 or 2025 or who knows when?